365 related articles for article (PubMed ID: 31629643)
1. Azithromycin is the answer in paediatric respiratory medicine, but what was the question?
Bush A
Paediatr Respir Rev; 2020 Apr; 34():67-74. PubMed ID: 31629643
[TBL] [Abstract][Full Text] [Related]
2. Long-term macrolide treatment for chronic respiratory disease.
Spagnolo P; Fabbri LM; Bush A
Eur Respir J; 2013 Jul; 42(1):239-51. PubMed ID: 23180583
[TBL] [Abstract][Full Text] [Related]
3. [LONG TERM TREATMENT WITH MACROLIDES IN CHRONIC LUNG DISEASES].
Shteinberg M; Schneer S; Lavon O; Adir Y
Harefuah; 2016 Sep; 155(9):567-571. PubMed ID: 28530085
[TBL] [Abstract][Full Text] [Related]
4. Role of long term antibiotics in chronic respiratory diseases.
Suresh Babu K; Kastelik J; Morjaria JB
Respir Med; 2013 Jun; 107(6):800-15. PubMed ID: 23522403
[TBL] [Abstract][Full Text] [Related]
5. Use of macrolides in lung diseases: recent literature controversies.
Silva Filho LV; Pinto LA; Stein RT
J Pediatr (Rio J); 2015; 91(6 Suppl 1):S52-60. PubMed ID: 26354869
[TBL] [Abstract][Full Text] [Related]
6. Rational use of mucoactive medications to treat pediatric airway disease.
Linssen RSN; Ma J; Bem RA; Rubin BK
Paediatr Respir Rev; 2020 Nov; 36():8-14. PubMed ID: 32653467
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
Amsden GW
J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715
[TBL] [Abstract][Full Text] [Related]
8. Past, present and future of macrolide therapy for chronic rhinosinusitis in Japan.
Shimizu T; Suzaki H
Auris Nasus Larynx; 2016 Apr; 43(2):131-6. PubMed ID: 26441370
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory effects of macrolides in lung disease.
Jaffé A; Bush A
Pediatr Pulmonol; 2001 Jun; 31(6):464-73. PubMed ID: 11389580
[TBL] [Abstract][Full Text] [Related]
10. Azithromycin or erythromycin? Macrolides for non-cystic fibrosis bronchiectasis in adults: A systematic review and adjusted indirect treatment comparison.
Li W; Qin Z; Gao J; Jiang Z; Chai Y; Guan L; Chen Y
Chron Respir Dis; 2019; 16():1479972318790269. PubMed ID: 30101613
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory activity and effectiveness of macrolides in chronic airway disease.
Rubin BK; Henke MO
Chest; 2004 Feb; 125(2 Suppl):70S-78S. PubMed ID: 14872003
[TBL] [Abstract][Full Text] [Related]
12. Role of macrolide therapy in chronic obstructive pulmonary disease.
Martinez FJ; Curtis JL; Albert R
Int J Chron Obstruct Pulmon Dis; 2008; 3(3):331-50. PubMed ID: 18990961
[TBL] [Abstract][Full Text] [Related]
13. N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.
Bosnar M; Kragol G; Koštrun S; Vujasinović I; Bošnjak B; Bencetić Mihaljević V; Marušić Ištuk Z; Kapić S; Hrvačić B; Brajša K; Tavčar B; Jelić D; Glojnarić I; Verbanac D; Culić O; Padovan J; Alihodžić S; Eraković Haber V; Spaventi R
J Med Chem; 2012 Jul; 55(13):6111-23. PubMed ID: 22697905
[TBL] [Abstract][Full Text] [Related]
14. Macrolides and airway inflammation in children.
Shinkai M; Rubin BK
Paediatr Respir Rev; 2005 Sep; 6(3):227-35. PubMed ID: 16153572
[TBL] [Abstract][Full Text] [Related]
15. Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?
King P
Drugs; 2007; 67(7):965-74. PubMed ID: 17488142
[TBL] [Abstract][Full Text] [Related]
16. Are the antimicrobial properties of macrolides required for their therapeutic efficacy in chronic neutrophilic airway diseases?
Brusselle GG
Thorax; 2015 May; 70(5):401-3. PubMed ID: 25870311
[No Abstract] [Full Text] [Related]
17. A review of non-cystic fibrosis bronchiectasis in children with a focus on the role of long-term treatment with macrolides.
El Boustany P; Gachelin E; Colomban C; Cernoia J; Sudour P; Carsin A; Dubus JC
Pediatr Pulmonol; 2019 Apr; 54(4):487-496. PubMed ID: 30652424
[TBL] [Abstract][Full Text] [Related]
18. Which patients with respiratory disease need long-term azithromycin?
Alchakaki A; Cramer C; Patterson A; Soubani AO
Cleve Clin J Med; 2017 Oct; 84(10):755-758. PubMed ID: 28985171
[No Abstract] [Full Text] [Related]
19. Risks of population antimicrobial resistance associated with chronic macrolide use for inflammatory airway diseases.
Serisier DJ
Lancet Respir Med; 2013 May; 1(3):262-74. PubMed ID: 24429132
[TBL] [Abstract][Full Text] [Related]
20. Macrolide antibiotics and bronchiolitis obliterans following lung transplantation.
Crowley S; Egan JJ
Expert Rev Anti Infect Ther; 2005 Dec; 3(6):923-30. PubMed ID: 16307505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
